Consolidated income statement

January 1 – December 31

millions of CHF	Notes	2022	2021 1)
Continuing operations
Sales from continuing operations	3, 21	3’179.9	3’155.3
Cost of goods sold		–2’240.3	–2’208.4
Gross profit from continuing operations		939.6	946.9
Selling and distribution expenses		–317.0	–309.2
General and administrative expenses		–363.0	–358.8
Research and development expenses	11	–66.4	–64.4
Net impairment loss on contract assets and trade accounts receivable	2	–39.9	–10.8
Other operating income / (expenses), net	12	–42.1	18.1
Operating income (EBIT) from continuing operations		111.4	221.8
Interest and securities income	13	9.7	10.4
Interest expenses	13	–27.3	–25.7
Other financial income / (expenses), net	13	16.0	–6.4
Share of profit / (loss) of associates	18	–2.7	–2.2
Income before income tax expenses from continuing operations		107.0	197.9
Income tax expenses	14	–79.0	–57.2
Net income from continuing operations		28.0	140.7
Net income from discontinued operations, net of tax	5	–	1’278.3
Net income		28.0	1’418.9
– thereof attributable to shareholders of Sulzer Ltd		28.6	1’416.7
– thereof attributable to non-controlling interests		–0.6	2.2

Earnings per share (in CHF)
Basic earnings per share	26	0.85	41.93
Diluted earnings per share	26	0.83	41.28

Earnings per share from continuing operations (in CHF)
Basic earnings per share from continuing operations	26	0.85	4.10
Diluted earnings per share from continuing operations	26	0.83	4.03

1) Comparative information has been re-presented: Net impairment loss on contract assets and trade accounts receivable was previously included in selling and distribution expenses.

Auditor’s report

Consolidated statement of comprehensive income